or 3-&alpha;-phenylpropyl-5-&beta;-diethylaminoethyl-1, 2, 4-oxadiazole citrate, is an unusual drug because it possesses both anti-inflammatory and antispasmodic proper ties (1) and because each of these two properties has some uncommon features. The anti inflammatory action takes place mostly against edematous responses and is devoid of ul cerogenic effects which are instead produced by most anti-inflammatory drugs; moreover proxazole prevents indomethacin-induced ulcers without exerting any anti-secretory effect (2-3). The antispasmodic activity results in a specific inhibition of smooth muscle spasm, both at the vascular and at the intestinal level, without significant interferences with the physiologic activity of that tissue (1-4).<BR>
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The above data suggested a potential interest in the use of proxazole in pathological situations sustained by ischemic-inflammatory processes. Therefore experiments were undertaken to test proxazole in rats operated according to Grollman (6) . In such animals the induced hypertension may be measured and used as an index of renal alterations.
METHODS

Animals
Long-Evans rats of both sexes weighing between 170 and 190 g were used. As no difference was recorded between male and female rats, the results were grouped together.
Each experiment was performed in groups of animals having homogeneous weight and arterial pressure values. Water and food were administered ad libitum.
Measurement of systolic arterial pressure
Systolic arterial pressure was measured in unanesthetized rats according to the Stanton and White (6) method, using an impulse transducer attached to the tail and registering the pulse beats on a Grass polygraph, mod. 5.
Production of renal hypertension
The Grollman (5) method was employed. Immediately after recording arterial pres sure, the rats were anesthetized with ether. The left kidney was then exposed and a figure of 8 ligation was performed around it. Fifteen days later the arterial pressure was re corded once again and the contralateral kidney was removed immediately afterwards.
The day of nephrectomy was conventionally indicated as 0 time as it corresponds in the majority of the experiments to the beginning of the treatment.
RESULTS
Trend of renal hypertension No significant differences were recorded between the arterial pressure of the control group and that of the group treated with proxazole. Fig. 3 summarizes the results obtained administering proxazole to rats operated ac cording to the Grollman (5) method. The drug was mixed in the diet at an 0.1 % con centration, and it was started from 0 day, corresponding to the day in which nephrectomy took place.
FIG. 3.
Effects of proxazole on arterial pressure of rats operated according to Grollman (5) . Proxazole (0.1% in the diet) was given for 44 days following nephrectomy. 43 control animals and 29 animals treated with proxazole were used.
Mean values and standard errors are reported. x P<0.05; +P<0.01; *P<0.001. The symbols in brackets refer to the comparison with the starting value; the others to the comparison between the con trol group and the treated group.
Control animals developed a marked and statistically significant hypertensive state starting from 15 days after nephrectomy. Blood pressure of animals treated with proxa zole remained significantly lower than in control animals all through the experiment; how ever a slight hypertension, which was statistically significant as compared to initial values, was observed 33 and 44 days after nephrectomy.
In a subsequent experiment rats operated according to the Grollman (5) method were subdivided into two groups: in the first group treatment with proxazole was effected for 50 days after nephrectomy and in the second group from the 50th to the 60th day after nephrectomy.
The concentration of proxazole in the diet was 0.1 % and the observation period after nephrectomy was 60 dyas. The results obtained are given in Fig. 4 .
In the first group arterial pressure was statistically lower than in the second group, both during treatment and after. By comparing pressure values recorded at various peri ods with the initial pressure values, it was found that a significant increase in pressure oc curred only on the 44th day after nephrectomy. In teh second group proxazole, which Fiu. 4. Effects of proxazole, administered according to different treat ment schemes, on the arterial pressure of rats operated according to Grollman (5) . Proxazole (0.1% in the diet) was given for 50 days following nephrectomy, in one group, for 10 days starting 50 days after nephrectomy in the second group. The first group consisted of 20 rats, the second of 19 rats.
Mean values and standard errors are reported. x P<0.05 ; +P<0.01 ; *P<0.001. The symbols in brackets refer to the comparison with the starting value ; the others to the comparison between the two groups. was given from the 50th up to 60th day after nephrectomy, produced no hypotensive effect.
In an attempt to determine the minimum duration of treatment with proxazole re quired to inhibit the hypertensive process, a group of 15 animals was treated with the drug for 15 days following nephrectomy. Treatment reduced the hypertensive response in comparison to what was observed in the corresponding control group (25 rats), but the effect was not statistically significant. In Fig. 5 are shown the results obtained by treat ing the animals with proxazole for 35 days following nephrectomy.
In the group treated with proxazole, arterial pressure remained significantly lower than in the control animals, both during treatment and during the 15 days which followed it.
Dose/(ffect relationship ri,ith proxazole A group of animals was treated with a diet containing 0.05 % of the drug. The ex periment was performed on 36 rats; 18 of them were treated for 44 days after nephrectomy, while the remaining 18 were used as control animals. Proxazole slightly reduced the hy pertensive response, but the difference between the control group did not reach statistical significance. It can therefore be concluded that the effective dose of proxazole ranges between 0.05 and 0.1 % in the diet.
Effects of proxazole on the death rate and body grotit,th of rats operated according to the Grollman (5) method The results obtained studying body weight increase are shown in Fig. 7 .
The experiment was conducted on 10 rats treated with proxazole (0.1% in the diet) for 60 days following nephrectomy and on 15 control rats. The increase in body weight is greater in the treated rats than in the control ones, but the difference is statistically sig nificant only at the last reading. Results are reported in Fig. 8 .
In the control animals the hypertensive response developed rather slowly and statis tically significant values, differently from whose observed in previous experiment, were obtained only 23 days after nephrectomy. In the group treated with papaverine the hy pertensive response was more marked that in the control animals. In the group treated with reserpine pressure values were maintained for more than half of the treatment period at lower levels than in the control animals. At the end of the test, however, arterial pres sure was the same both in the control group and in the one treated with reserpine.
The test with dihydrochlorothiazide was carried out on 14 rats on the whole, 7 of which were treated with the drug (0.01 `, in the diet for 44 days following nephrectomy) while the other 7 were used as control animals. In both groups a similar hypertensive response was observed.
DISCUSSION
These experiments demonstrate that the administration of proxazole with the diet to rats operated according to the Grollman (5) method prevents the appearence of hy pertension or markedly reduces it. This effect was obtained by starting treatment im mediately after nephrectomy and it continued even when treatment was discontinued.
It was also observed that proxazole did not exert any hypotensive effect either in normal rats or in rats nephrectomized 50 days beforehand, in which the hypertensive process was already established.
Reserpine, given with the diet to rats operated according to Grollman (5) , has pro duced a hypotensive effect during the first stage of treatment. This result is in accordance with previous tests performed by administering the drug either in a single dose or every day for 4 weeks (7-9).
The fact that at the end of the experiment no significant difference was found between control and reserpine treated rats, would suggest that a process of re sistance to the drug develops when administration is prolonged. In the same experimental conditions, both papaverine and dihydrochlorothiazide proved to be inactive. Negative results obtained with dihydrochlorothiazide confirm previous investigations (10) (11) , ac cording to which benzothiadiazine diuretics reduce the desoxycorticosterone-induced hypertension, but not renal hypertension.
The most striking results of these experiments lies in the observation that proxazole possesses a specific preventive action on renal hypertension. Therefore this result shall be discussed in details. In this connection, it must be borne in mind that in the renal hy pertension three components can be distinguished: a) An inflammatory and ischemic process of the kidney.
A protective action at this level must theoretically result in a prevention of the hy pertensive response, without any interference with the arterial pressure of normal animals or of animals in which the hypertension is already established and is linked to degenerative and necrotic phenomena which are irreversible in their nature. Proxazole is, to our know ledge, the first drug showing such a spectrum of effects.
b) The activation of the renin-angiotensin system.
An inhibition, of this system should produce an anti-hypertensive but not hypotensive, effect; namely arterial pressure should be reduced in hypertensive, but not in normal ani mals. This had been observed by Sell et al. (12) with a phospholipid having anti-renin properties.
c) The response of structures, which normally control arterial pressure, to renin and
angiotensin.
An inhibition of these structures should produce an hypotensive effect both in normal and hypertensive animals, which is the case of most drugs actually used in the therapy of arterial hypertension.
Therefore the specific preventive action of proxazole on renal hypertension produced in rats according to the Grollman (5) method confirms the working hypothesis that this drug may improve, due to its unusual features, the trophism of tissues suffering from is chemic-inflammatory conditions. This interpretation is in good agreement with experi mental observations, according to which proxazole prevents enzymatic depletion produced in the kidney by acute ischemia (13) , as well as with clinical results showing a therapeutic action of this drug in kidney diseases due to ischernic-inflammatory processes (14) .
SUMMARY
1. The effect of prolonged administration of proxazole on arterial pressure both in normal rats and in rats operated according to the Grollman (5) method were studied. The drug was administered in the diet, starting in most cases from the day of contralateral nephrectomy.
2. Proxazole did not exert any effect either in normal rats or in rats where the hy pertensive response had already manifested itself and had become stable.
3. When treatment with proxazole began immediately after nephrectomy and was prolonged for at least 35 days, the hypertensive response was greatly reduced and it re mained at low values even after discontinuing the treatment.
4. Papaverine, reserpine and dihydrochlorothiazide were studied in rats operated according to the Grollman (5) method using the same treatment schedule used with pro xazole. Papaverine and dihydrochlorothiazide proved to be devoid of anti-hypertensive effects, whereas reserpine exerted more complex effects: at the beginning of treatment a hypotensive action was observed, but at the end of the experiment pressure values of both treated and control animals were equally high.
5. Results are also discussed from the point of view of their possible therapeutic implications.
